- /
- Supported exchanges /
- PINK /
- RICFY.PINK
Recordati Industria Chimica e Farmaceutica S.p.A. (RICFY PINK) stock market data APIs
Recordati Industria Chimica e Farmaceutica S.p.A. Financial Data Overview
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in Italy and internationally. It operates through Specialty and Primary Care and Rare Diseases segments. The company's product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS for the treatment of cystine crystal deposits in the cornea. It also develops CARBAGLU for hyperammonemia due to NAGS deficiency; QARZIBA, an apeiron for the treatment of high-risk neuroblastoma patients with a partial response at the chemotherapeutical through myeloablative therapy and stem cell transplantation, and relapsed or refractory neuroblastoma; and FOTIVDA, an oral inhibitor first-line treatment of renal cell carcinoma. In addition, the company offers SYLVANT for the treatment of idiopathic multicentric castleman diseases; REAGILA for Schizophrenia; and ELIGARD for hormone-dependent prostate cancer, as well as CAPHOSOL, a medical device for treatment electrolyte supersaturated of oral mucositis due to chemo and radiation therapy. Recordati Industria Chimica e Farmaceutica S.p.A. was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. is a subsidiary of Rossini S.à R.L.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Recordati Industria Chimica e Farmaceutica S.p.A. data using free add-ons & libraries
Get Recordati Industria Chimica e Farmaceutica S.p.A. Fundamental Data
Recordati Industria Chimica e Farmaceutica S.p.A. Fundamental data includes:
- Net Revenue: 2 269 M
- EBITDA: 837 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Recordati Industria Chimica e Farmaceutica S.p.A. Earnings data
What’s included:
- Latest Release: 2024-11-08
- EPS/Forecast: NaN
Get Recordati Industria Chimica e Farmaceutica S.p.A. End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.